1Betarbet R, Sherer TB, Greensmyre JT. Animal models of Parkinson's disease. Bioessays,2002,24(4): 308 - 318
2Shimohama S, Sawada H, Kitamura Y et al . Disease model: Parkinson's disease. Trends Mol Med,2003,9(8) :360 - 365
3Schallert T, Teitelbaum P. Haloperidol, catalepsy and equilibrating functions in the rat: an antagonist interaction of clinging and labyrinthine righting reactions. Physiol Behav, 1981,27(6), 1 077 -1 083
4Ungerstedt U. 6- hydroxydopamine induced degeneration of central monoamine neurons. Eur J Pharmacol, 1968,5(1): 107- 110
5Zigmond MJ, Abercrombie ED, Berger TW et al . Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci, 1990,13(7): 290 - 296
6Sarre S, Herregodts P, DeleuDetal .Biotransformation of L- dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study. Naunyn Schmiedebergs Arch Pharmacol, 1992,346(3) :277 - 285
7Thomas J, Wang J, Takubo H et al . A 6 - hydroxydopamine - induced selective parkinsonian rat model: further biochemical and behavioural characterization. Exp Neurol, 1994,126(2): 159 - 167
8Yuan H, Sarre S, Ebinger G et al . Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6 - OHDA lesions as rat models of Parkinson's disease. J Neurosci Methods,2005,144(1) :35 -45
9Yuan H, Sarre S, Ebinger G et al . Neuroprotective and neurotrophic effect of apomorphine in the striatal 6 - OHDA - lesion rat model of Parkinson's disease. Brain Res, 2004,1 026(1 ) :95 - 107
10Vila M, Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci,2003,4(5):365- 375
5Hong Yuan, Sophie Sarre, Guy Ebinger et al . Histological, behavioural and neumchemical evaluation of medial forebrain bundle and striatal 6 - OHDA lesions as rat models of Parkinson' s disease. Journal of Neuroscience Methods, 2005,144:35.
6Paxinos G, Watson C. The Rat Brain in stereotaxic Coordinates M. Second Edition USA: San Diego, A cademic Press 1998.36.
7Henze C, Earl C, Sautter J et al . Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6 - hydroxydopamine lesion in rats. Brain Res, 2005, 1052 (1):97.
8SunM, Kong L, Wang X et al . comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson' s disease. Brain Res, 2005, 1052 (2):119.
9Debeir T, Ginestet L, Francois C et al . Effect of intrastriatal 6- OHDA Lesion on dopeminergic innervation of the rat cortex and globus pallidus. Exp Neurol, 2005,193(2 ):444.
10Berretta N, Freestone PS, Guatteo E et al .Acute effects of 6 - hydroxydopcmine on dopcminergic neurons of the rat substantianigra pars compacta in vitro. Neurotoxicology, 2005, 26(5) :869.
